Goldman Sachs Group Inc. lowered shares of Celgene Corp. (NASDAQ:CELG) from a neutral rating to a sell rating in a research report released on Monday morning, TheFlyOnTheWall.com reports. Celgene Corporation (NASDAQ:CELG) stock opened at $164.94 in last session, and closed at $164.61, while the day range of stock is $164.33 – $166.82. The stock showed a negative weekly performance of -2.59%.
Investment analysts at Credit Suisse assumed coverage on shares of Starbucks Corp. (NASDAQ:SBUX) in a note issued to investors on Tuesday, American Banking and Market News reports. The firm set an “outperform” rating on the stock. Starbucks Corporation (NASDAQ:SBUX) stock opened at $76.65, in last session and closed at $77.21, by gaining 1.37%. The 52 week range of the stock is $52.52 – $82.50. Company’s market capitalization is $58.19 billion.
The share price of Korean company Celltrion Inc rose nearly 10% on the Seoul Stock Exchange yesterday after reports in the South Korean media that Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) was one of several pharmaceutical giants in talks to acquire the biotech firm. Reports named Roche Holding AG, and AstraZeneca Plc. as also holding acquisition talks with Celltrion. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock increased 1.78% and finished the last session at $41.21. The EPS of the stock remained 0.42. Company’s market capitalization is $39.02 billion.
Anglo American (LON:AAL)‘s stock had its “neutral” rating reaffirmed by investment analysts at Credit Suisse in a note issued to investors on Wednesday, American Banking & Market News reports. Anglo American plc (LON:AAL) stock opened the session at $1,266.00, and closed the session at $1,272.50. The 52 week range of the stock remained $1,195.50 – $2,088.50 and the day range was $1,265.00 – $1,280.79.